Trial
NCT02974322
A Study of Efficacy and Safety of Mongersen (GED-0301) for the Treatment of Adult and Adolescent Subjects With Active Crohn's Disease
Phase IIIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Celgene
Collaborators
—
Condition
Crohn Disease
Intervention
GED-0301
Why stopped
Sponsor decision not to start trial
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-11-14